For the quarter ending 2025-09-30, ACRV has $145,299K in assets. $16,696K in debts. $35,405K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 35,405 | 41,895 | ||
| Short-term investments | 93,849 | 95,528 | ||
| Prepaid expenses and other current assets | 1,107 | 989 | ||
| Total current assets | 130,361 | 138,412 | ||
| Total property and equipment | 8,146 | - | ||
| Less accumulated depreciation | 2,957 | - | ||
| Property and equipment, net | 5,189 | 5,072 | ||
| Operating lease right-of-use assets | 2,792 | 3,052 | ||
| Long-term investments | 5,108 | 10,199 | ||
| Restricted cash | 202 | 201 | ||
| Other assets | 1,647 | 1,647 | ||
| Total assets | 145,299 | 158,583 | ||
| Accounts payable | 996 | 1,163 | ||
| Accrued expenses and other current liabilities | 12,711 | 11,120 | ||
| Operating lease liabilities, current | 1,184 | 1,148 | ||
| Total current liabilities | 14,891 | 13,431 | ||
| Operating lease liabilities, non-current | 1,805 | 2,115 | ||
| Total liabilities | 16,696 | 15,546 | ||
| Common stock, 0.001 par value 500,000,000 shares authorized as of september 30, 2025 and december 31, 2024 31,549,770 and 31,231,264 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 31 | 31 | ||
| Additional paid-in capital | 384,356 | 380,562 | ||
| Accumulated other comprehensive income | 112 | 106 | ||
| Accumulated deficit | -255,896 | -237,662 | ||
| Total stockholders' equity | 128,603 | 143,037 | ||
| Total liabilities and stockholders' equity | 145,299 | 158,583 | ||
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)